Last updated: April 24, 2026

Application No. 19/347,194

Untitled Application

Unknown

Filed

1600

Examiner

GONZALEZ, LUISALBERTO

Art Unit

1624

Tech Center

SK CHEMICALS Co., Ltd.

Assignee

SK Chemicals Co. Ltd.

OA Round

1 (Non-Final)

This examiner grants 62% of cases after interview

— +48.4% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 136 resolved cases, 2023–2026

Examiner Intelligence

GONZALEZ, LUISALBERTO View full profile →

Grants 62% of resolved cases

Career Allow Rate

85 granted / 136 resolved

+2.5% vs TC avg

Strong +48% interview lift

Without

With

+48.4%

Interview Lift

resolved cases with interview

Typical timeline

2y 9m

Avg Prosecution

56 currently pending

Career history

192

Total Applications

across all art units

Statute-Specific Performance

§101

2.8%

-37.2% vs TC avg

§103

37.2%

-2.8% vs TC avg

§102

12.6%

-27.4% vs TC avg

§112

29.4%

-10.6% vs TC avg

Black line = Tech Center average estimate • Based on career data from 136 resolved cases

Prosecution Timeline

1600

Application Filed

Dec 09, 2025

Non-Final Rejection (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/616,236

Patent 12595261

P2X3 AND/OR P2X2/3 RECEPTOR ANTAGONIST, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF

2y 5m to grant Granted Apr 07, 2026

17/098,171

Patent 12590062

PD-1/PD-L1 INHIBITORS

2y 5m to grant Granted Mar 31, 2026

18/764,635

Patent 12590110

AMORPHOUS (A-POLYMORPHIC) PSILOCYBIN

2y 5m to grant Granted Mar 31, 2026

17/442,688

Patent 12583869

SALT FORM AND CRYSTAL FORM OF A2A RECEPTOR ANTAGONIST AND PREPARATION METHOD THEREFOR

2y 5m to grant Granted Mar 24, 2026

17/817,853

Patent 12583838

ANALOGS FOR THE TREATMENT OF DISEASE

2y 5m to grant Granted Mar 24, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.

Prosecution Projections

1-2

Expected OA Rounds

62%

Grant Probability

99%

With Interview (+48.4%)

2y 9m

Median Time to Grant

Low

PTA Risk

Based on 136 resolved cases by this examiner. Grant probability derived from career allow rate.